Clinical Trials Browser

Carcinoid Heart Disease, Heart Failure, Heart Valve Diseases, Neuroendocrine Tumors, Serotonin Syndrome

NCT04993261 2026-02-19

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

Phase EARLY_PHASE1 Active not recruiting

71 enrolled

Endocrine

Carcinoid Tumor, Serotonin Syndrome

NCT05064514 2025-05-01

TRICAR

Phase NA Active not recruiting

15 enrolled

Endocrine

Carcinoid Heart Disease, Carcinoid Tumor, Tricuspid Valve Insufficiency, Serotonin Syndrome

NCT03453489 2025-04-10

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

Phase 2 Completed

4 enrolled 7 charts

Serotonin Syndrome

NCT04713202 2023-02-10

NET-PACS

Phase 2 Withdrawn

EndocrineNET

Diarrhea, Neuroendocrine Tumors, Serotonin Syndrome

NCT03722511 2022-11-03

Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs

Phase 2 Completed

10 enrolled

EndocrineNET

Diarrhea, Neuroendocrine Tumors, Serotonin Syndrome

NCT04776876 2021-09-29

Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome

Phase 2 Withdrawn

Serotonin Syndrome

NCT04073017 2021-05-21

Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency

Phase NA Terminated

11 enrolled

EndocrineNET

Neuroendocrine Tumors, Serotonin Syndrome

NCT04039516 2020-08-04

CHARRT

Phase 2 Unknown

20 enrolled

Endocrine

Carcinoid Heart Disease, Carcinoid Tumor, Serotonin Syndrome

NCT04140409 2019-10-25

SCIROCCO

Phase 4 Terminated

10 enrolled

EndocrineNET

Neuroendocrine Tumors, Serotonin Syndrome

NCT01172717 2013-07-26

Study of Panitumumab in the Treatment of Carcinoid Syndrome

Phase 2 Withdrawn

Endocrine

Carcinoid Tumor, Serotonin Syndrome

NCT00789841 2010-10-26

Gastrointestinal Motility in Patients With Neuroendocrine Tumors

Completed

13 enrolled

EndocrineNET

Neuroendocrine Tumors, Serotonin Syndrome

Clinical Trials

CardioNETPOL

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

TRICAR

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

NET-PACS

Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs

Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome

Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency

CHARRT

SCIROCCO

Study of Panitumumab in the Treatment of Carcinoid Syndrome

Gastrointestinal Motility in Patients With Neuroendocrine Tumors